Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RB1 Activators

Chemical activators of V1RB1 include a variety of compounds that interact with different receptor-mediated pathways leading to its activation. Acetylcholine, for example, activates muscarinic and nicotinic receptors, which can result in downstream signaling events involving calcium fluxes and kinases that activate V1RB1. Similarly, nicotine targets nicotinic acetylcholine receptors, and this interaction leads to an influx of calcium ions into the cell. The change in intracellular calcium levels can activate a range of kinases that, in turn, activate V1RB1. Capsaicin, known for activating TRPV1 receptors, also results in calcium influx into cells, and this cascade of events can activate V1RB1 through the action of downstream kinases.

Further activation of V1RB1 can be achieved by ATP, which binds to purinergic receptors and initiates a signaling cascade that results in increased intracellular calcium and kinase activation, leading to V1RB1 activation. Serotonin and histamine, which interact with their respective receptors, 5-HT and H1 or H2, initiate signaling cascades that also involve calcium mobilization and kinase activity, culminating in the activation of V1RB1. Dopamine and adrenaline engage with G-protein coupled receptors and adrenergic receptors, respectively, to activate adenylate cyclase, increase intracellular cAMP, and activate protein kinase A (PKA), which then activates V1RB1. Noradrenaline and isoproterenol interact similarly with adrenergic receptors, leading to PKA activation and, subsequently, V1RB1 activation. Lastly, forskolin directly activates adenylate cyclase, thereby raising cAMP levels within the cell and activating PKA, which can lead to the activation of V1RB1 through phosphorylation events. Each of these chemicals initiates a specific cellular pathway that culminates in the activation of V1RB1, showcasing the diverse mechanisms through which this protein can be regulated.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Capsaicin

404-86-4sc-3577
sc-3577C
sc-3577D
sc-3577A
50 mg
250 mg
500 mg
1 g
$96.00
$160.00
$240.00
$405.00
26
(1)

Capsaicin activates TRPV1 receptors, resulting in calcium influx and activation of downstream kinases, which can activate V1RB1.

ADP

58-64-0sc-507362
5 g
$54.00
(0)

ATP binds to purinergic receptors, leading to calcium signaling and kinase activation, which may activate V1RB1.

Serotonin hydrochloride

153-98-0sc-201146
sc-201146A
100 mg
1 g
$118.00
$187.00
15
(1)

Serotonin interacts with 5-HT receptors, initiating signal transduction pathways that lead to V1RB1 activation through phosphorylation by downstream kinases.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Histamine engages with H1 or H2 receptors, which can lead to intracellular signaling cascades involving calcium mobilization and kinase activation, ultimately activating V1RB1.

Dopamine

51-61-6sc-507336
1 g
$290.00
(0)

Dopamine interacts with its G-protein coupled receptors, leading to cAMP production which can activate PKA and subsequently V1RB1.

L-Glutamic Acid

56-86-0sc-394004
sc-394004A
10 g
100 g
$297.00
$577.00
(0)

Glutamate acts on its receptors causing calcium influx and activation of calcium-dependent kinases that can activate V1RB1.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Adrenaline binds to adrenergic receptors, which can activate adenylate cyclase, increasing cAMP and activating PKA, leading to the activation of V1RB1.

L-Noradrenaline

51-41-2sc-357366
sc-357366A
1 g
5 g
$326.00
$485.00
3
(0)

Noradrenaline interacts with adrenergic receptors, potentially increasing cAMP levels and activating PKA, which may lead to V1RB1 activation.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, a beta-adrenergic agonist, can increase cAMP in cells, activating PKA, and potentially leading to the activation of V1RB1.